Viewing Study NCT06606210



Ignite Creation Date: 2024-10-25 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06606210
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-13

Brief Title: INNOVEN Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care SOC Versus SOC Alone
Sponsor: None
Organization: None

Study Overview

Official Title: An Observer-Blinded Multicenter Randomized Controlled Trial Evaluating Porcine Placental Extracellular Matrix as an Adjunct to Standard of Care Versus Standard of Care Alone in Hard-to-Heal Venous Leg Ulcers
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: INNOVEN is a multi-center randomized controlled clinical trial to evaluate the efficacy of porcine placental extracellular matrix PPECM and standard of care SOC versus SOC alone in the closure of non-healing venous leg ulcers VLUs
Detailed Description: An Observer-Blinded Multicenter Randomized Controlled Trial Evaluating Porcine Placental Extracellular Matrix as an Adjunct to Standard of Care versus Standard of Care Alone in Hard-to-Heal Venous Leg Ulcers

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None